Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1083-1086

  Tan, Chalet ^a   Waldmann, Thomas A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; FC RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; PROTEASOME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA REMISSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T CELL LEUKEMIA;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; CYSTEINE ENDOPEPTIDASES; DNA, NEOPLASM; DNA-BINDING PROTEINS; DRUG SYNERGISM; HUMANS; I-KAPPA B PROTEINS; IMMUNOGLOBULIN G; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MICE; MICE, INBRED NOD; MICE, SCID; MONOCYTES; MULTIENZYME COMPLEXES; NEUTROPHILS; NF-KAPPA B; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; RECEPTORS, IGG;

EID: 0036172154     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hostile takeover: Viral appropriation of the NF-κB pathway
2. Human T-cell leukemia virus type I Tax protein abrogates interlukin-2 dependence in a mouse T-cell line
3. + T lymphocytes by human T-cell leukemia virus type I Tax mutants expressed in a functional molecular clone
4. Inactivation of p53 by human T-cell lymphotrophic virus type I Tax requires activation of the NF-κB pathway and is dependent on p53 phosphorylation
5. Ablation of transplanted HTLV-I Tax transformed tumors in mice by antisense inhibition of NF-κB
6. The NF-κB and IκB proteins: New discoveries and insights
7. Human T-cell leukemia virus type I Tax activation of NF-κB/Rel involves phosphorylation and degradation of IκBα and RelA (p65)-mediated induction of the c-rel gene
8. Persistent activation of NF-κB/Rel by human T-cell leukemia virus type I Tax involves degradation of IκBβ
9. Inactivation of IκBβ by Tax protein of human T-cell leukemia virus type I: A potential mechanism for constitutive induction of NF-κB
10. Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids
11. Characterization of peptidyl boronic acid inhibitors of mammalian 20S and 26S proteasomes and their inhibition of proteasomes in cultured cells
12. Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis
13. The proteasome inhibitor PS-341 in cancer therapy
14. The promiscuous IL-2/IL15 receptor: A target for immunotherapy of HTLV-I-associated disorders
15. IL-2Rα-directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia (ATL) by a mechanism other than blockade of IL-2/IL-2Rα interaction
16. HTLV-1 Tax induces cellular proteins that activate the κB element in IL-2 receptor A gene
17. Constitutive activation of NF-κB in primary adult T-cell leukemia cells
18. Proteasome inhibition: A new strategy in cancer treatment
19. The ubiquitin-proteasome pathway: On protein death and cell life